Últimos Artículos de Diabetologia
- Adipocyte-derived exosomal ANGPTL2 promotes beta cell dysfunction via the EIF2α/ATF4/CHOP stress pathway in mice
- BAF60A governs beta cell identity to control systemic glucose homeostasis
- Environmental sustainability of offloading care pathways for people with a diabetes-related foot ulcer: a life-cycle assessment
- Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- Type 2 diabetes subtypes, aetiology and pathophysiology
- Efficacy of the digital therapeutic glucura combined with CGM in the treatment of type 2 diabetes: a randomised controlled trial over 6 months
- Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
- Correction: The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- Interpreting beta cell function after total pancreatectomy with islet autotransplantation: the overlooked role of exocrine pancreatic function
- Type 2 diabetes subtypes, aetiology and pathophysiology. Reply to Vaag A [letter]
- Choosing diabetes technology in children and adolescents: beyond preference to fit
- Safety of glucagon-like peptide-1 receptor agonists and other new-generation glucose-lowering agents for the management of type 2 diabetes in pregnancy: a French nationwide population-based study
- The insulin resistance mosaic: defect, defence or both? A perspective on what insulin resistance means and whether it should be treated
- Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention – Immune Tolerance trial
- Insulin resistance in the 21st century: new takes on an old problem—2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum
- The impact of physical activity and exercise timing on metabolic health among individuals at high risk of type 2 diabetes
- Lifestyle and environmental risk factors for adult-onset autoimmune diabetes: current evidence and future directions
- Sphinganine as a novel stimulator of GLP-1 secretion
- Up Front
- Insulin pens and the digital ecosystem